Rapacuronium

Rapacuronium Uses, Dosage, Side Effects, Food Interaction and all others data.

Rapacuronium was withdrawn in 2001 in many countries due to risk of fatal bronchospasm.

Rapacuronium is a rapidly acting, non-depolarizing neuromuscular blocker.

Table Of contents

• Rapacuronium
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Rapacuronium
Availability	Discontinued
Generic	Rapacuronium
Type
Formula	C37H61N2O4
Weight	Average: 597.904 Monoisotopic: 597.462584872
Protein binding	Variable. Plasma protein binding of rapacuronium was studied in vitro for human plasma by equilibrium dialysis. The protein binding was variable and ranged between 50% and 88%, which was at least partly due to hydrolysis of rapacuronium bromide to its 3-hydroxy metabolite. The specific plasma protein to which rapacuronium binds is unknown. Plasma protein binding of the 3-hydroxy metabolite was not determined.
Groups	Approved, Withdrawn
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Rapacuronium is a nondepolarizing neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures.

Used in anaesthesia, to aid and enable endotracheal intubation.

Rapacuronium Disease Interaction

Major: burns, histamine release, myasthenia gravis, paresis, pulmonary impair

Half Life

141 minutes (mean)

Innovators Monograph

You find simplified version here Rapacuronium